Published: 2018-12-08

Articles

BUILDING A STRUCTURED MONITORING AND EVALUATING SYSTEM OF POSTMARKETING DRUG USE IN SHANGHAI

Wenmin Du, Mitchell Levine, Longxing Wang, Chengdong Yi, Hongmin Wang, Xiaoyu Wang, Hongjuan Xie Xie, Jianglong Xu, Huilin Jin, Tongchun Wang, Gang Huang, Ye Wu
Abstract 131 | PDF Downloads 96

COUNSELING REGARDING PREGNANCY- RELATED DRUG EXPOSURES BY FAMILY PHYSICIANS IN ONTARIO

Jodi Goodwin, Scott Rieder, Michael J Rieder, Doreen Matsui
Abstract 101 | PDF Downloads 66

45 YEARS LATER… WHERE DO WE STAND?

Mercédes Benegbi
Abstract 107 | PDF Downloads 63

PAEDIATRIC ADVERSE DRUG REACTION REPORTING: UNDERSTANDING AND FUTURE DIRECTIONS

Bruce C Carleton, M Anne Smith, Michaela N Gelin, Susan C Heathcote
Abstract 382 | PDF Downloads 163

DRUGS IN PREGNANCY: ACKNOWLEDGING CHALLENGES - FINDING SOLUTIONS

Gideon Koren, Stuart MacLeod, Donald Davis
Abstract 413 | PDF Downloads 88

DRUGS USED IN PREGNANCY: THE REGULATORY PROCESS

Anne Tomalin
Abstract 124 | PDF Downloads 186

THE WAY WOMEN PERCEIVE TERATOGENIC RISK

Gideon Koren
Abstract 498 | PDF Downloads 199

INACTIVE PHARMACEUTICAL INGREDIENTS: IMPLICATIONS FOR PREGNANCY

Yaron Finkelstein, Massoud Rezvani, Facundo Garcia-Bournissen, Laila Nurmohamed, Gideon Koren
Abstract 967 | PDF Downloads 452

CHALLENGES IN DRUG USE NEAR TERM AND DURING DELIVERY

Dan Farine
Abstract 101 | PDF Downloads 67

COLLECTION AND ANALYSIS OF DRUG SAFETY DATA IN PREGNANCY

Myla Moretti
Abstract 77 | PDF Downloads 61

COLLECTION AND ANALYSIS OF DRUG SAFETY DATA IN PREGNANCY

Myla Moretti
Abstract 84 | PDF Downloads 52

CRITICAL APPRAISAL ROUNDS: A NEW TRAINING MODEL FOR CLINICAL PHARMACOLOGISTS

Gideon Koren, Irena Nulman
Abstract 381 | PDF Downloads 69

USE OF CELECOXIB IMMEDIATELY POST MARKETING IN CANADA: ACUTE OR CHRONIC PAI N?

Anita L Kozyrskyj, Colette Raymond, Amber Racher Racher
Abstract 105 | PDF Downloads 80